BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38778711)

  • 21. Surgery and clinicopathological features of gastric adenocarcinoma involving the esophago-gastric junction.
    Koufuji K; Shirouzu K; Aoyagi K; Yano S; Miyagi M; Imaizumi T; Takeda J
    Kurume Med J; 2005; 52(3):73-9. PubMed ID: 16422172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma.
    Schwameis K; Green KM; Worrell SG; Samaan J; Cooper S; Tatishchev S; Oh DS; Hagen JA; DeMeester SR
    Ann Surg Oncol; 2017 Dec; 24(13):3921-3925. PubMed ID: 28975518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thoracoabdominal gastrectomy and distal 2/3 esophageal resection with wide lymph node dissection for type II and III adenocarcinoma at the gastro-esophageal junction.
    Jeremiasen M; Walther B; Djerf P; Staël von Holstein C; Zilling T; Hermansson M; Falkenback D; Johansson J
    Am J Surg; 2019 Aug; 218(2):329-334. PubMed ID: 30635210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgical treatment of Barrett carcinoma].
    Fuchs KH
    Zentralbl Chir; 2000; 125(5):443-9. PubMed ID: 10929629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous Resection of Synchronous Esophageal and Gastric Cancers.
    Park B; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
    Thorac Cardiovasc Surg; 2016 Oct; 64(7):611-618. PubMed ID: 27148930
    [No Abstract]   [Full Text] [Related]  

  • 28. Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centers?
    Hanna GB; Boshier PR; Knaggs A; Goldin R; Sasako M
    Arch Surg; 2012 Aug; 147(8):738-45. PubMed ID: 22911070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II).
    Ruol A; Merigliano S; Baldan N; Santi S; Petrin GF; Bonavina L; Ancona E; Peracchia A
    Dis Esophagus; 1997 Jul; 10(3):190-5. PubMed ID: 9280078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
    Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
    Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.
    Talsma K; van Hagen P; Grotenhuis BA; Steyerberg EW; Tilanus HW; van Lanschot JJ; Wijnhoven BP
    Ann Surg Oncol; 2012 Jul; 19(7):2142-8. PubMed ID: 22395974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.
    Swanson SJ; Batirel HF; Bueno R; Jaklitsch MT; Lukanich JM; Allred E; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2001 Dec; 72(6):1918-24; discussion 1924-5. PubMed ID: 11789772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit.
    Kalff MC; Wagner AD; Verhoeven RHA; Lemmens VEPP; van Laarhoven HWM; Gisbertz SS; van Berge Henegouwen MI;
    Gastric Cancer; 2022 Jan; 25(1):22-32. PubMed ID: 34365540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
    Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carcinomas of the esophago-gastric junction: surgical strategies].
    Siegel G; Wagner M; Seiler Ch
    Swiss Surg; 2003; 9(3):121-6. PubMed ID: 12815832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction.
    Reeh M; Mina S; Bockhorn M; Kutup A; Nentwich MF; Marx A; Sauter G; Rösch T; Izbicki JR; Bogoevski D
    Br J Surg; 2012 Oct; 99(10):1406-14. PubMed ID: 22961520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).
    van der Sluis PC; Ruurda JP; van der Horst S; Verhage RJ; Besselink MG; Prins MJ; Haverkamp L; Schippers C; Rinkes IH; Joore HC; Ten Kate FJ; Koffijberg H; Kroese CC; van Leeuwen MS; Lolkema MP; Reerink O; Schipper ME; Steenhagen E; Vleggaar FP; Voest EE; Siersema PD; van Hillegersberg R
    Trials; 2012 Nov; 13():230. PubMed ID: 23199187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors.
    Sauvanet A; Mariette C; Thomas P; Lozac'h P; Segol P; Tiret E; Delpero JR; Collet D; Leborgne J; Pradère B; Bourgeon A; Triboulet JP
    J Am Coll Surg; 2005 Aug; 201(2):253-62. PubMed ID: 16038824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.